“Development of novel drugs for the treatment of intractable neuromuscular diseases based on innovative oligonucleotide therapeutics technologies” was selected for the “Research and Development Program for Innovative Biologics” in 2024.

Please click here (go to the web page of the Japan Agency for Medical Research and Development) for more information (Japanese only).